PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.\', \'Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany.\', \'Biological Data Science Institute, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.\', \'Australian National University Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia.\', \'Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia.\', \'Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia.\', \'China Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Jiaotong University, Shanghai, China.\', \'Department of Immunology Canberra Hospital, Canberra, Australia.\', \'ANU Medical School, Australian National University, Canberra, Australia.\', \'The Canberra Hospital, Infectious Diseases, Canberra, Australia.\', \'Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.\', \'Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Australia.\', \'Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine.\', \'Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'College of Health and Medicine, The Australian National University, Canberra, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/infdis/jiaa623
?:doi
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33009908
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all